Pharmaceutical PV DIV - FSB
Ended Awarded Last action
- Contract number
- SPE2DU26FEHZU
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $99,505
Award facts
- Contract value 100% obligated
- $99,504.78 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $99,504.78 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This delivery order, issued on December 18, 2025, with an ultimate completion date of December 19, 2025, was awarded without a set-aside designation. DMS Pharmaceutical Group is the sole awardee with no identified subcontractors on this action. The delivery order falls under the company's larger Indefinite Delivery Contract (SPE2DR) within the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to provide comprehensive pharmaceutical supply support to Department of Defense medical facilities worldwide.
As a critical supplier within the federal pharmaceutical supply chain, DMS Pharmaceutical Group supplies a diverse portfolio of products including branded and generic prescription medications, over-the-counter drugs, biologics, vaccines, specialty pharmaceuticals, and medical consumables to support military healthcare operations. The company's broader PPV-G GEN V contract, valued at $499,999,999 and awarded on November 13, 2025, establishes a 30-month base period with three 30-month option periods extending through December 31, 2036. This delivery order represents one of numerous DLA Medical Supply Chain awards issued to the company, demonstrating its consistent performance capability across multiple therapeutic categories and product lines essential to Department of Defense operations.
Quick answers
Who was awarded contract SPE2DU26FEHZU?
SPE2DU26FEHZU was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 18, 2025.
How much is contract SPE2DU26FEHZU worth?
The government has obligated $99,505 on SPE2DU26FEHZU.
Is contract SPE2DU26FEHZU an order under another contract?
Yes. SPE2DU26FEHZU is a delivery order under SPE2DU25D9415, an indefinite delivery contract.
Was contract SPE2DU26FEHZU competed?
The extent of competition for SPE2DU26FEHZU was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award